Search results
Should You Buy This Stock After a Regulatory Setback?
Motley Fool via Yahoo Finance· 6 hours agoIts late-stage pipeline is exciting. The company is running phase 3 studies for a combination...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoThe disclosure came amid a run-up in shares of vaccine makers. Moderna stock spiked in Wednesday...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 4 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoThe biotech could become an AI winner down the road, but does this make the stock a buy? Let's find out. Image source: Getty Images. Moderna's peak ...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 5 hours agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
The growing promise of cancer vaccines
Cosmos· 14 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 3 days agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 6 days agovaccine makers say that the Food and Drug Administration’s delay in designing this fall’s Covid-19 ...
